The whole genome sequence of most human bacterial pathogens is available and the advent of next-generation sequencing technologies will result in a large number of sequenced isolates per pathogenic species. The study of multiple genome sequences of a given bacterium provides insights into its evolution, pathogenic potential and diversity. The pathogen’s pan-genome, defined as the sum of the core genome shared by all sequenced strains and the dispensable genome present only in a subset of the isolates, can be analyzed to assess the size and diversity of the gene repertoire that the species has access to. This information is then used to better inform the reverse vaccinology approach whereby vaccine candidates are identified and prioritized in silico based on genomic data. Bioinformatics integration of genome sequence data with functional genomics results and clinical meta-data is essential to maximize the use of this large amount of information to answer biologically relevant questions.
© 2009 S. Karger AG, Basel
Number of Print Pages : 13
Book Serie: Genome Dynamics, Vol. 6, Year 2009
Editor(s): Volff, J.-N. (Lyon)
ISSN: 1660-9263 (Print), eISSN: 1662-3797 (Online)
For additional information:
Book Title: Microbial Pathogenomics
Editor(s): de Reuse H, Bereswill S (eds)
For additional information:
Article / Publication Details
Published online: 8/19/2009
Cover Date: 2009
Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0
ISBN: 978-3-8055-9192-8 (Print)
eISBN: 978-3-8055-9193-5 (Online)
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.